Publications by authors named "Hadar Goldvaser"

Claim this Profile
H
Heterogeneity of Primary Outcomes in Large Atherosclerotic Cardiovascular Disease Trials Published in Prominent Medical Journals.
Daniel Shepshelovich, Dafna Yahav, Danielle R Rome, Hadar Goldvaser, Ilan Richter

JAMA Intern Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort.
Daniela Katz, Ilan Feldhamer, Yael Wolff-Sagy, Hadar Goldvaser, Ariel Hammerman

Breast Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct-to-implant Prepectoral Breast Reconstruction in Women Older Than 65 Years: Analysis of Safety and Patient-reported Outcome.
Adi Maisel Lotan, Yotam Teldan, Ronen Toledano, Shahar Talisman, Shalom Strano, Hadar Goldvaser

Plast Reconstr Surg Glob Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.
Hadar Goldvaser, Rinat Yerushalmi, Raz Mutai, Iryna Kuchuk, Margarita Toker

Breast Cancer Res Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-escalation of surgical and radiation treatment in elderly luminal breast cancer patients, single institution report and review of the evidence.
Yasmin Korzets, Marian Khatib, Hadar Goldvaser, Yehiel Hibshoosh, Alla Nikolaevski-Berlin

World J Surg Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review.
Areen Abu Remilah, Bilal Krayim, Eitan Amir, Ariadna Tibau, Mark E Robson, Hadar Goldvaser

Crit Rev Oncol Hematol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy.
Raz Mutai, Iryna Kuchuk, Alexandra Goldshtein, Rinat Yerushalmi, Ofer Rotem, Hadar Goldvaser

Breast Cancer Res Treat· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review.
Shlomit Strulov Shachar, Yasmin Korzets, Daniel Shepshelovich, Noa Zlothover, Eitan Amir, Hadar Goldvaser

Cancer Treat Rev· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry.
Shlomit S Shachar, Michelle Leviov, Rinat Yerushalmi, Karen Drumea, Margarita Tokar, Hadar Goldvaser

NPJ Breast Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.
Ofer Rotem, Idit Peretz, Michelle Leviov, Iryna Kuchuk, Amit Itay, Hadar Goldvaser

NPJ Breast Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy.
Ofer Rotem, Alona Zer, Lilach Yosef, Einat Beery, Hadar Goldvaser

Biomedicines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecularly Confirmed Female Donor-Transmitted Lobular Breast Cancer to Male following Renal Transplantation.
Jonah M Cooper, Benzion Samueli, Elad Mazor, Waleed Kian, Hadar Goldvaser

Pathobiology· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of adjuvant radiotherapy on clinical, imaging, and patient reported outcomes in implant-based breast reconstruction - Pilot study of a new scale for evaluating breast changes on MRI.
Adi Maisel Lotan, Ronen Toledano, Yazid Kassem, Shalom Strano, David Gekthman, Hadar Goldvaser

J Plast Reconstr Aesthet Surg· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis.
Yasmin Korzets, Dina Levitas, Ahuva Grubstein, Benjamin W Corn, Eitan Amir, Hadar Goldvaser

Curr Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome.
Ido Laish, Zohar Levi, Hussein Mahajna, Ahmad Albshesh, Nir Horesh, Hadar Goldvaser

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis.
Adi Pomerantz, Daliah Tsoref, Ahuva Grubstein, Sonya Wadhawker, Yael Rapson, Hadar Goldvaser

Breast Cancer Res Treat· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Pathogenic Variants in and : Malignancies Beyond Female Breast and Ovarian Cancers.
Sari Lieberman, Hadar Goldvaser, Ephrat Levy-Lahad

J Clin Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[RAPIDLY PROGRESSING PARAPARESIS AND LOSS OF SENSATION BELOW T10 DURING NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER].
Orly Yariv, Alexandra Benouaich-Amiel, Tanseem Kab, Shlomit Yust-Katz, Rinat Yerushalmi, Hadar Goldvaser

Harefuah· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer.
Raz Mutai, Tamar Barkan, Assaf Moore, Michal Sarfaty, Tzippy Shochat, Hadar Goldvaser

Breast· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies for immune thrombocytopenic purpura: a meta-analysis of randomized controlled trials.
Inbar Cohen, Hadar Goldvaser, Ilya Kirgner, Avi Leader, Pia Raanani

Ann Hematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Soran et al.
Daniel Reinhorn, Eitan Amir, Hadar Goldvaser

Breast· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Exogenous Estrogen Exposure on the Characteristics and Outcome of Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer.
Orly Yariv, Raz Mutai, Ofer Rotem, Daliah Tsoref, Yasmin Korzets, Hadar Goldvaser

Oncology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis.
Dor Reuven Dabush, Daniel Shepshelovich, Tzippy Shochat, Ariadna Tibau, Eitan Amir, Hadar Goldvaser

Cancer Treat Rev· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer.
Yasmin Korzets, Orly Yariv, Raz Mutai, Assaf Moore, Tzippy Shochat, Hadar Goldvaser

Discov Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Assaf Moore, Yael Bar, Corinne Maurice-Dror, Inbar Finkel, Hadar Goldvaser

Medicine (Baltimore)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis